查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
冯维勒布兰德病(VWD)治疗市场规模、市场份额、应用分析、区域展望、增长趋势、主要参与者、竞争战略和预测，2023-2031年
市场调查报告书
商品编码
1283948

冯维勒布兰德病(VWD)治疗市场规模、市场份额、应用分析、区域展望、增长趋势、主要参与者、竞争战略和预测，2023-2031年

Von Willebrand Disease (VWD) Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 To 2031
出版日期: | 出版商: Acute Market Reports | 英文 118 Pages | 商品交期: 最快1-2个工作天内

价格

到 2031 年，冯维勒布兰德病 (VWD) 治疗市场预计将增长 5.5%。 根据世界血友病联合会 (WFH) 的说法，血管性血友病 (VWD) 是最常见的出血性疾病类型。 VWD 患者的血液中存在一种名为血管性血友病因子 (VWF) 的蛋白质，这种蛋白质有助于控制出血。 当血管受损和出血时，VWF 帮助血液中称为血小板的细胞结合在一起并形成凝块以止血。 据专家称，VWD 影响了世界上约 1% 的人口，但很少有人知道它，因为症状非常轻微。 研究表明，十分之九的人未被确诊。 von Willebrand病治疗市场根据von Willebrand病的类型分为1型、2型和3型。 用于 von Willebrand 病的治疗类型有去氨加压素 (DDAVP)、激素替代疗法、避孕药、抗纤维蛋白溶解药或血栓稳定剂以及纤维蛋白密封剂。

最近，Teva 和 Eagle Pharmaceuticals 的 Bendeka（苯达莫司汀）产品获得 FDA 批准，作为一种新的製剂用于慢性淋巴细胞白血病和 B 细胞非霍奇金淋巴瘤，可以在更短的时间内以更小的体积通过输液，稻田。 根据 2 月份与 Eagle 签署的协议，Teva 拥有 Bendeka 在美国的商业权利，併计划在 2016 年第一季度推出该疗法。

冯维勒布兰德病增长的一个主要驱动因素是公众对冯维勒布兰德病的认识提高，这推动了北美和欧洲诊断率的提高。 北美被认为是血管性血友病治疗的最大市场，其次是欧洲。 在 2016-2022 年的预测期内，亚太地区预计将以最快的复合年增长率增长。 支持亚太地区冯维勒布兰德病治疗市场增长的关键因素是提高对罕见疾病的认识、发展医疗保健基础设施、高可支配收入以及政府对罕见遗传病新疗法的支持。。

内容

第 1 章前言

  • 报告内容
    • 报告的目的
    • 目标受众
    • 主要产品
  • 市场细分
  • 调查方法
    • 第一阶段 - 二次调查
    • 第二阶段 - 初步调查
    • 第三阶段 - 专家评审
    • 先决条件
    • 采用的方法

第 2 章执行摘要

  • 市场概况：全球血管性血友病 (VWD) 药物市场
  • 2022 年按疾病分类的全球血管性血友病 (VWD) 治疗市场
  • 全球冯维勒布兰德病 (VWD) 治疗市场：（按药物）2022 年
  • 2022 年按给药途径划分的全球血管性血友病 (VWD) 治疗市场
  • 2022 年按地区划分的全球血管性血友病 (VWD) 治疗市场
  • 有吸引力的投资建议：按地区划分，2022 年

第 3 章冯维勒布兰德病 (VWD) 药物市场：竞争分析

  • 主要供应商的市场定位
  • 供应商采用的策略
  • 主要产业战略
  • 等级分析：2022 年与 2031 年

第 4 章血管性血友病 (VWD) 治疗市场：宏观分析和市场动态

  • 介绍
  • 2021-2031 年全球冯维勒布兰德病 (VWD) 药物市场价值
  • 市场动态
    • 市场促进因素
    • 市场抑制因素
    • 主要问题
    • 主要机会
  • 促进因素和抑制因素的影响分析
  • 跷跷板分析

第 5 章按疾病分类的冯维勒布兰德病 (VWD) 药物市场 2021-2031

  • 市场概览
  • 增长和收益分析：2022 年与 2031 年
  • 市场细分
    • 1 型冯维勒布兰德病
    • 2 型冯维勒布兰德病
    • 3 型冯维勒布兰德病
    • 获得性血管性血友病

第 6 章2021-2031 年按药物分类的冯维勒布兰德病 (VWD) 药物市场

  • 市场概览
  • 增长和收益分析：2022 年与 2031 年
  • 市场细分
    • 去氨加压素
    • 血栓稳定剂
    • 替代疗法
    • 避孕药
    • 其他

第 7 章按给药途径划分的冯维勒布兰德病 (VWD) 药物市场 2021-2031

  • 市场概览
  • 增长和收益分析：2022 年与 2031 年
  • 市场细分
    • 口服
    • 注射
    • 其他

第 8 章北美冯维勒布兰德病 (VWD) 药物市场 2021-2031

  • 市场概览
  • 2021-2031 年按疾病分类的冯维勒布兰德病 (VWD) 药物市场
  • 2021-2031 年按药物分类的冯维勒布兰德病 (VWD) 治疗市场
  • 2021-2031 年按给药途径划分的冯维勒布兰德病 (VWD) 药物市场
  • 2021-2031 年按地区划分的冯维勒布兰德病 (VWD) 药物市场
    • 北美
      • 美国
      • 加拿大
      • 其他北美地区

第 9 章英国和欧盟 von Willebrand 病 (VWD) 治疗市场 2021-2031

  • 市场概览
  • 2021-2031 年按疾病分类的冯维勒布兰德病 (VWD) 药物市场
  • 2021-2031 年按药物分类的冯维勒布兰德病 (VWD) 治疗市场
  • 2021-2031 年按给药途径划分的冯维勒布兰德病 (VWD) 药物市场
  • 2021-2031 年按地区划分的冯维勒布兰德病 (VWD) 药物市场
    • 英国和欧盟
      • 英国
      • 德国
      • 西班牙
      • 意大利
      • 法国
      • 其他欧洲地区

第 10 章亚太地区冯维勒布兰德病 (VWD) 药物市场 2021-2031

  • 市场概览
  • 2021-2031 年按疾病分类的冯维勒布兰德病 (VWD) 药物市场
  • 2021-2031 年按药物分类的冯维勒布兰德病 (VWD) 治疗市场
  • 2021-2031 年按给药途径划分的冯维勒布兰德病 (VWD) 药物市场
  • 2021-2031 年按地区划分的冯维勒布兰德病 (VWD) 药物市场
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区

第 11 章拉丁美洲冯维勒布兰德病 (VWD) 药物市场 2021-2031

  • 市场概览
  • 2021-2031 年按疾病分类的冯维勒布兰德病 (VWD) 药物市场
  • 2021-2031 年按药物分类的冯维勒布兰德病 (VWD) 治疗市场
  • 2021-2031 年按给药途径划分的冯维勒布兰德病 (VWD) 药物市场
  • 2021-2031 年按地区划分的冯维勒布兰德病 (VWD) 药物市场
    • 拉丁美洲
      • 巴西
      • 墨西哥
      • 其他拉丁美洲地区

第 12 章中东和非洲冯维勒布兰德病 (VWD) 治疗市场 2021-2031

  • 市场概览
  • 2021-2031 年按疾病分类的冯维勒布兰德病 (VWD) 药物市场
  • 2021-2031 年按药物分类的冯维勒布兰德病 (VWD) 治疗市场
  • 2021-2031 年按给药途径划分的冯维勒布兰德病 (VWD) 药物市场
  • 2021-2031 年按地区划分的冯维勒布兰德病 (VWD) 药物市场
    • 中东和非洲
      • 海湾合作委员会
      • 非洲
      • 其他中东和非洲地区

第 13 章公司简介

  • Octapharma AG
  • Grifols S.A.
  • Shire plc
  • Bayer AG
  • CSL Behring
  • Pfizer Inc.
  • Akorn Inc.
  • Ferring B.V.
  • 其他受注目玩家
Product Code: 136862-05-23

Von Willebrand Disease (VWD) Treatment Market is Expected to Grow at 5.5% by 2031. According to World Federation of Hemophilia (WFH), von Willebrand disease (VWD) is the most common type of bleeding disorder. People with VWD have a problem with a protein in their blood called von Willebrand factor (VWF) that helps control bleeding. When a blood vessel is injured and bleeding occurs, VWF helps cells in the blood, called platelets, mesh together and form a clot to stop the bleeding. According to market experts, around 1% of the world's population suffers from VWD, but due to presence of very mild symptoms only a few number of patients are aware about the condition. Research has shown that as many as 9 out of 10 people with VWD have not been diagnosed. On the basis of type of VWD, von Willebrand disease treatment market can be segmented as Type 1 VWD, Type 2 VWD and Type 3 VWD. The types of therapeutic treatments used against von Willebrand disease are Desmopressin (DDAVP), hormone replacement therapy, contraceptives, anti-fibrinolytic or clot-stabilizing drugs, and fibrin sealants.

Recently, the FDA has approved Bendeka (bendamustine) product of Teva and Eagle Pharmaceuticals, a novel drug formulation that can be administered via a shorter, lower-volume infusion - for chronic lymphocytic leukaemia and B-cell non-Hodgkin's lymphoma.It was observed that Teva received US commercialisation rights to Bendeka under a deal with Eagle signed in February, and plans to launch the therapy during the first quarter of 2016.

The key factor responsible for growth of von Willebrand disease is increasing public awareness related to VWD which is fueling the diagnosis rate in North America and Europe. North America was observed as the largest market for von Willebrand disease treatment followed by Europe. Asia Pacific was anticipated to grow at a fastest CAGR during the forecast period 2016 to 2022. The key factors assisting the growth of Asia Pacific von Willebrand disease treatment market are the rising awareness associated with the rare diseases, developing healthcare infrastructure, high disposable income and government support for novel treatment against rare genetic diseases.

Key Players Identified for von Willebrand disease (VWD) Treatment Market Include but are Not Limited to:

Octapharma AG, Crifols, S.A., Shire plc, Bayer AG, CSL Behring, Pfizer, Inc., Akorn, Inc., Ferring B.V. Other Notable Players.

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Von Willebrand Disease (VWD) Treatment market are as follows:

  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Von Willebrand Disease (VWD) Treatment market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Disease Type

  • Type 1 von Willebrand Disease
  • Type 2 von Willebrand Disease
  • Type 3 von Willebrand Disease
  • Acquired von Willebrand Disease

Drug

  • Desmopressin
  • Clot-stabilizing Medications
  • Replacement Therapies
  • Contraceptives
  • Others

Route of Administration

  • Oral
  • Injection
  • Others

Region Segment (2021-2031; US$ Million)

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • UK and European Union
    • UK
    • Germany
    • Spain
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Key questions answered in this report:

  • What are the key micro and macro environmental factors that are impacting the growth of Von Willebrand Disease (VWD) Treatment market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2031.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Von Willebrand Disease (VWD) Treatment market?
  • Which is the largest regional market for Von Willebrand Disease (VWD) Treatment market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Von Willebrand Disease (VWD) Treatment market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Von Willebrand Disease (VWD) Treatment market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Von Willebrand Disease (VWD) Treatment Market
  • 2.2. Global Von Willebrand Disease (VWD) Treatment Market, By Disease Type, 2022 (US$ Million)
  • 2.3. Global Von Willebrand Disease (VWD) Treatment Market, By Drug, 2022 (US$ Million)
  • 2.4. Global Von Willebrand Disease (VWD) Treatment Market, By Route of Administration, 2022 (US$ Million)
  • 2.5. Global Von Willebrand Disease (VWD) Treatment Market, By Geography, 2022 (US$ Million)
  • 2.6. Attractive Investment Proposition by Geography, 2022

3. Von Willebrand Disease (VWD) Treatment Market: Competitive Analysis

  • 3.1. Market Positioning of Key Von Willebrand Disease (VWD) Treatment Market Vendors
  • 3.2. Strategies Adopted by Von Willebrand Disease (VWD) Treatment Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2022 Versus 2031

4. Von Willebrand Disease (VWD) Treatment Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Von Willebrand Disease (VWD) Treatment Market Value, 2021 - 2031, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis

5. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 5.3. Market Segmentation
    • 5.3.1. Type 1 von Willebrand Disease
    • 5.3.2. Type 2 von Willebrand Disease
    • 5.3.3. Type 3 von Willebrand Disease
    • 5.3.4. Acquired von Willebrand Disease

6. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 6.3. Market Segmentation
    • 6.3.1. Desmopressin
    • 6.3.2. Clot-stabilizing Medications
    • 6.3.3. Replacement Therapies
    • 6.3.4. Contraceptives
    • 6.3.5. Others

7. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)

  • 7.1. Market Overview
  • 7.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 7.3. Market Segmentation
    • 7.3.1. Oral
    • 7.3.2. Injection
    • 7.3.3. Others

8. North America Von Willebrand Disease (VWD) Treatment Market, 2021-2031, USD (Million)

  • 8.1. Market Overview
  • 8.2. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
  • 8.3. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
  • 8.4. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)
  • 8.5.Von Willebrand Disease (VWD) Treatment Market: By Region, 2021-2031, USD (Million)
    • 8.5.1.North America
      • 8.5.1.1. U.S.
        • 8.5.1.1.1. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
        • 8.5.1.1.1. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
        • 8.5.1.1.1. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)
      • 8.5.1.2. Canada
        • 8.5.1.2.1. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
        • 8.5.1.2.1. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
        • 8.5.1.2.1. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)
      • 8.5.1.3. Rest of North America
        • 8.5.1.3.1. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
        • 8.5.1.3.1. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
        • 8.5.1.3.1. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)

9. UK and European Union Von Willebrand Disease (VWD) Treatment Market, 2021-2031, USD (Million)

  • 9.1. Market Overview
  • 9.2. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
  • 9.3. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
  • 9.4. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)
  • 9.5.Von Willebrand Disease (VWD) Treatment Market: By Region, 2021-2031, USD (Million)
    • 9.5.1.UK and European Union
      • 9.5.1.1. UK
        • 9.5.1.1.1. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
        • 9.5.1.1.1. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
        • 9.5.1.1.1. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)
      • 9.5.1.2. Germany
        • 9.5.1.2.1. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
        • 9.5.1.2.1. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
        • 9.5.1.2.1. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)
      • 9.5.1.3. Spain
        • 9.5.1.3.1. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
        • 9.5.1.3.1. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
        • 9.5.1.3.1. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)
      • 9.5.1.4. Italy
        • 9.5.1.4.1. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
        • 9.5.1.4.1. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
        • 9.5.1.4.1. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)
      • 9.5.1.5. France
        • 9.5.1.5.1. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
        • 9.5.1.5.1. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
        • 9.5.1.5.1. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)
      • 9.5.1.6. Rest of Europe
        • 9.5.1.6.1. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
        • 9.5.1.6.1. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
        • 9.5.1.6.1. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)

10. Asia Pacific Von Willebrand Disease (VWD) Treatment Market, 2021-2031, USD (Million)

  • 10.1. Market Overview
  • 10.2. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
  • 10.3. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
  • 10.4. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)
  • 10.5.Von Willebrand Disease (VWD) Treatment Market: By Region, 2021-2031, USD (Million)
    • 10.5.1.Asia Pacific
      • 10.5.1.1. China
        • 10.5.1.1.1. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
        • 10.5.1.1.1. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
        • 10.5.1.1.1. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)
      • 10.5.1.2. Japan
        • 10.5.1.2.1. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
        • 10.5.1.2.1. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
        • 10.5.1.2.1. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)
      • 10.5.1.3. India
        • 10.5.1.3.1. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
        • 10.5.1.3.1. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
        • 10.5.1.3.1. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)
      • 10.5.1.4. Australia
        • 10.5.1.4.1. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
        • 10.5.1.4.1. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
        • 10.5.1.4.1. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)
      • 10.5.1.5. South Korea
        • 10.5.1.5.1. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
        • 10.5.1.5.1. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
        • 10.5.1.5.1. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)
      • 10.5.1.6. Rest of Asia Pacific
        • 10.5.1.6.1. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
        • 10.5.1.6.1. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
        • 10.5.1.6.1. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)

11. Latin America Von Willebrand Disease (VWD) Treatment Market, 2021-2031, USD (Million)

  • 11.1. Market Overview
  • 11.2. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
  • 11.3. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
  • 11.4. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)
  • 11.5.Von Willebrand Disease (VWD) Treatment Market: By Region, 2021-2031, USD (Million)
    • 11.5.1.Latin America
      • 11.5.1.1. Brazil
        • 11.5.1.1.1. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
        • 11.5.1.1.1. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
        • 11.5.1.1.1. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)
      • 11.5.1.2. Mexico
        • 11.5.1.2.1. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
        • 11.5.1.2.1. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
        • 11.5.1.2.1. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)
      • 11.5.1.3. Rest of Latin America
        • 11.5.1.3.1. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
        • 11.5.1.3.1. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
        • 11.5.1.3.1. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)

12. Middle East and Africa Von Willebrand Disease (VWD) Treatment Market, 2021-2031, USD (Million)

  • 12.1. Market Overview
  • 12.2. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
  • 12.3. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
  • 12.4. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)
  • 12.5.Von Willebrand Disease (VWD) Treatment Market: By Region, 2021-2031, USD (Million)
    • 12.5.1.Middle East and Africa
      • 12.5.1.1. GCC
        • 12.5.1.1.1. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
        • 12.5.1.1.1. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
        • 12.5.1.1.1. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)
      • 12.5.1.2. Africa
        • 12.5.1.2.1. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
        • 12.5.1.2.1. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
        • 12.5.1.2.1. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)
      • 12.5.1.3. Rest of Middle East and Africa
        • 12.5.1.3.1. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
        • 12.5.1.3.1. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
        • 12.5.1.3.1. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)

13. Company Profile

  • 13.1. Octapharma AG
    • 13.1.1. Company Overview
    • 13.1.2. Financial Performance
    • 13.1.3. Product Portfolio
    • 13.1.4. Strategic Initiatives
  • 13.2. Grifols, S.A.
    • 13.2.1. Company Overview
    • 13.2.2. Financial Performance
    • 13.2.3. Product Portfolio
    • 13.2.4. Strategic Initiatives
  • 13.3. Shire plc
    • 13.3.1. Company Overview
    • 13.3.2. Financial Performance
    • 13.3.3. Product Portfolio
    • 13.3.4. Strategic Initiatives
  • 13.4. Bayer AG
    • 13.4.1. Company Overview
    • 13.4.2. Financial Performance
    • 13.4.3. Product Portfolio
    • 13.4.4. Strategic Initiatives
  • 13.5. CSL Behring
    • 13.5.1. Company Overview
    • 13.5.2. Financial Performance
    • 13.5.3. Product Portfolio
    • 13.5.4. Strategic Initiatives
  • 13.6. Pfizer, Inc.
    • 13.6.1. Company Overview
    • 13.6.2. Financial Performance
    • 13.6.3. Product Portfolio
    • 13.6.4. Strategic Initiatives
  • 13.7. Akorn, Inc.
    • 13.7.1. Company Overview
    • 13.7.2. Financial Performance
    • 13.7.3. Product Portfolio
    • 13.7.4. Strategic Initiatives
  • 13.8. Ferring B.V.
    • 13.8.1. Company Overview
    • 13.8.2. Financial Performance
    • 13.8.3. Product Portfolio
    • 13.8.4. Strategic Initiatives
  • 13.9. Other Notable Players
    • 13.9.1. Company Overview
    • 13.9.2. Financial Performance
    • 13.9.3. Product Portfolio
    • 13.9.4. Strategic Initiatives

List of Tables

  • TABLE 1 Global Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
  • TABLE 2 Global Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
  • TABLE 3 Global Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 4 North America Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
  • TABLE 5 North America Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
  • TABLE 6 North America Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 7 U.S. Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
  • TABLE 8 U.S. Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
  • TABLE 9 U.S. Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 10 Canada Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
  • TABLE 11 Canada Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
  • TABLE 12 Canada Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 13 Rest of North America Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
  • TABLE 14 Rest of North America Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
  • TABLE 15 Rest of North America Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 16 UK and European Union Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
  • TABLE 17 UK and European Union Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
  • TABLE 18 UK and European Union Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 19 UK Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
  • TABLE 20 UK Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
  • TABLE 21 UK Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 22 Germany Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
  • TABLE 23 Germany Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
  • TABLE 24 Germany Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 25 Spain Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
  • TABLE 26 Spain Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
  • TABLE 27 Spain Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 28 Italy Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
  • TABLE 29 Italy Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
  • TABLE 30 Italy Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 31 France Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
  • TABLE 32 France Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
  • TABLE 33 France Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 34 Rest of Europe Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
  • TABLE 35 Rest of Europe Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
  • TABLE 36 Rest of Europe Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 37 Asia Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
  • TABLE 38 Asia Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
  • TABLE 39 Asia Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 40 China Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
  • TABLE 41 China Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
  • TABLE 42 China Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 43 Japan Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
  • TABLE 44 Japan Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
  • TABLE 45 Japan Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 46 India Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
  • TABLE 47 India Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
  • TABLE 48 India Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 49 Australia Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
  • TABLE 50 Australia Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
  • TABLE 51 Australia Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 52 South Korea Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
  • TABLE 53 South Korea Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
  • TABLE 54 South Korea Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 55 Latin America Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
  • TABLE 56 Latin America Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
  • TABLE 57 Latin America Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 58 Brazil Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
  • TABLE 59 Brazil Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
  • TABLE 60 Brazil Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 61 Mexico Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
  • TABLE 62 Mexico Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
  • TABLE 63 Mexico Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 64 Rest of Latin America Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
  • TABLE 65 Rest of Latin America Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
  • TABLE 66 Rest of Latin America Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 67 Middle East and Africa Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
  • TABLE 68 Middle East and Africa Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
  • TABLE 69 Middle East and Africa Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 70 GCC Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
  • TABLE 71 GCC Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
  • TABLE 72 GCC Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 73 Africa Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
  • TABLE 74 Africa Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
  • TABLE 75 Africa Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 76 Rest of Middle East and Africa Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
  • TABLE 77 Rest of Middle East and Africa Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
  • TABLE 78 Rest of Middle East and Africa Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)

List of Figures

  • FIG. 1 Global Von Willebrand Disease (VWD) Treatment Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Von Willebrand Disease (VWD) Treatment Market: Quality Assurance
  • FIG. 5 Global Von Willebrand Disease (VWD) Treatment Market, By Disease Type, 2022
  • FIG. 6 Global Von Willebrand Disease (VWD) Treatment Market, By Drug, 2022
  • FIG. 7 Global Von Willebrand Disease (VWD) Treatment Market, By Route of Administration, 2022
  • FIG. 8 Global Von Willebrand Disease (VWD) Treatment Market, By Geography, 2022
  • FIG. 9 Market Geographical Opportunity Matrix - Global Von Willebrand Disease (VWD) Treatment Market, 2022
  • FIG. 10 Market Positioning of Key Von Willebrand Disease (VWD) Treatment Market Players, 2022
  • FIG. 11 Global Von Willebrand Disease (VWD) Treatment Market - Tier Analysis - Percentage of Revenues by Tier Level, 2022 Versus 2031
  • FIG. 12 Global Von Willebrand Disease (VWD) Treatment Market, By Disease Type, 2022 Vs 2031, %
  • FIG. 13 Global Von Willebrand Disease (VWD) Treatment Market, By Drug, 2022 Vs 2031, %
  • FIG. 14 Global Von Willebrand Disease (VWD) Treatment Market, By Route of Administration, 2022 Vs 2031, %
  • FIG. 15 U.S. Von Willebrand Disease (VWD) Treatment Market (US$ Million), 2021 - 2031
  • FIG. 16 Canada Von Willebrand Disease (VWD) Treatment Market (US$ Million), 2021 - 2031
  • FIG. 17 Rest of North America Von Willebrand Disease (VWD) Treatment Market (US$ Million), 2021 - 2031
  • FIG. 18 UK Von Willebrand Disease (VWD) Treatment Market (US$ Million), 2021 - 2031
  • FIG. 19 Germany Von Willebrand Disease (VWD) Treatment Market (US$ Million), 2021 - 2031
  • FIG. 20 Spain Von Willebrand Disease (VWD) Treatment Market (US$ Million), 2021 - 2031
  • FIG. 21 Italy Von Willebrand Disease (VWD) Treatment Market (US$ Million), 2021 - 2031
  • FIG. 22 France Von Willebrand Disease (VWD) Treatment Market (US$ Million), 2021 - 2031
  • FIG. 23 Rest of Europe Von Willebrand Disease (VWD) Treatment Market (US$ Million), 2021 - 2031
  • FIG. 24 China Von Willebrand Disease (VWD) Treatment Market (US$ Million), 2021 - 2031
  • FIG. 25 Japan Von Willebrand Disease (VWD) Treatment Market (US$ Million), 2021 - 2031
  • FIG. 26 India Von Willebrand Disease (VWD) Treatment Market (US$ Million), 2021 - 2031
  • FIG. 27 Australia Von Willebrand Disease (VWD) Treatment Market (US$ Million), 2021 - 2031
  • FIG. 28 South Korea Von Willebrand Disease (VWD) Treatment Market (US$ Million), 2021 - 2031
  • FIG. 29 Rest of Asia Von Willebrand Disease (VWD) Treatment Market (US$ Million), 2021 - 2031
  • FIG. 30 Brazil Von Willebrand Disease (VWD) Treatment Market (US$ Million), 2021 - 2031
  • FIG. 31 Mexico Von Willebrand Disease (VWD) Treatment Market (US$ Million), 2021 - 2031
  • FIG. 32 Rest of Latin America Von Willebrand Disease (VWD) Treatment Market (US$ Million), 2021 - 2031
  • FIG. 33 GCC Von Willebrand Disease (VWD) Treatment Market (US$ Million), 2021 - 2031
  • FIG. 34 Africa Von Willebrand Disease (VWD) Treatment Market (US$ Million), 2021 - 2031
  • FIG. 35 Rest of Middle East and Africa Von Willebrand Disease (VWD) Treatment Market (US$ Million), 2021 - 2031